Testing an electrical stimulation device for urinary leakage after prostate cancer treatment

Plain-English translation of NCT06161506 on ClinicalTrials.gov ↗ · Source last updated July 2026 · Translation generated July 2026 · How we translate trials

What is this trial?

This trial is testing the Elidah device, a surface electrical stimulation device designed to strengthen the pelvic floor muscles and reduce urinary leakage in men treated for prostate cancer. The device has already been approved by the FDA for women with urinary incontinence and has been adapted for use in men. Researchers want to see if this treatment can help men regain bladder control without needing surgery.

Urinary leakage is a common and frustrating side effect of prostate cancer treatment that significantly impacts quality of life. While pelvic floor exercises are the standard first step, many men struggle to stick with them or don't see improvement, and surgery is often the only remaining option. This trial explores whether the device could offer an easier, non-surgical alternative.

Do you qualify?

You likely qualify if…

you are a man aged 18 or older
you have experienced urinary leakage for at least 6 months after prostate cancer treatment
your urinary leakage is moderate, meaning you use 1 to 4 pads per day
you have either stress incontinence (leakage during physical activity, coughing, or sneezing) or urge incontinence (sudden, hard-to-control need to urinate)
you are able to read and write in English and are willing to sign an informed consent form

You likely don't qualify if…

you have a history of urinary retention or other complex urinary problems
you have had 4 or more urinary tract infections in the past 12 months
you have metal implants in your abdomen or pelvis, an implanted heart device, or a history of heart rhythm problems
you have severe obesity (BMI greater than 35) or uncontrolled chronic cough
you have a history of epilepsy, neurological disorders affecting the bladder, or pelvic pain syndromes

What participation looks like

You would use the Elidah device at home for 20 minutes per day, 5 days per week. Before starting, you'll complete baseline assessments including a 24-hour pad test and questionnaires about your incontinence symptoms and quality of life. Throughout the study, you'll continue using the device as instructed and return for follow-up visits to measure whether your leakage has improved.

Testing an electrical stimulation device for urinary leakage after prostate cancer treatment

What is this trial?

Do you qualify?

What participation looks like

Trial locations(1 site)